From human embryonic stem cells to billions of human insulin producing cells

Harvard stem cell researchers today announced that they have made a giant leap forward in the quest to find a truly effective treatment for type 1 diabetes, a condition that affects an estimated three million Americans at a cost of about $15…


Early innovation but a significant breakthrough in Diabetes PRECLINICAL research. Great potential if successfully translated into human clinical trials. 

See on Scoop.itStem cell news